anmelden
SMI
13.135,43
PKT
-147,83
PKT
-1,11
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 02.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.22 | Novartis Market-Perform | Bernstein Research | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 02.02.22 | Zurich Insurance Overweight | Barclays Capital | |
| 02.02.22 | UBS Equal Weight | Barclays Capital | |
| 02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.22 | UBS Outperform | Credit Suisse Group | |
| 02.02.22 | UBS Outperform | RBC Capital Markets | |
| 02.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.02.22 | Givaudan Hold | Deutsche Bank AG | |
| 01.02.22 | UBS Outperform | RBC Capital Markets | |
| 01.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.02.22 | UBS Buy | Jefferies & Company Inc. | |
| 31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Givaudan Hold | Deutsche Bank AG | |
| 31.01.22 | Swiss Re Hold | Deutsche Bank AG | |
| 31.01.22 | Novartis Underweight | Barclays Capital | |
| 31.01.22 | Roche Overweight | Barclays Capital | |
| 31.01.22 | Givaudan Underweight | Barclays Capital | |
| 31.01.22 | Givaudan Add | Baader Bank | |
| 31.01.22 | Givaudan Underperform | Credit Suisse Group | |
| 31.01.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.01.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 31.01.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.01.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 28.01.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 28.01.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.01.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 28.01.22 | Givaudan Add | Baader Bank | |
| 28.01.22 | Givaudan Underperform | Bernstein Research | |
| 27.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 27.01.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.01.22 | Swiss Re Sell | UBS AG | |
| 26.01.22 | UBS Buy | Jefferies & Company Inc. | |
| 26.01.22 | Roche Buy | Deutsche Bank AG | |
| 26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.